Ann Biomed Eng
Annals of Biomedical Engineering
0090-6964
1521-6047
Kluwer Academic Publishers-Plenum Publishers
New York


1764593
17031595
9179
10.1007/s10439-006-9179-4
Article


NFAT and NFκB Activation in T Lymphocytes: A Model of Differential Activation of Gene Expression

Fisher
Wayne G.

1
2

Yang
Pei-Chi

3

Medikonduri
Ram K.

2

Jafri
M. Saleet

sjafri@gmu.edu

3
4

1
Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, TX 75390 USA 
2
Department of Mathematical Sciences, The University of Texas at Dallas, Dallas, TX 75083 USA 
3
Department of Bioinformatics and Computational Biology, George Mason University, 10900 University Blvd. MSN 5B3, Manassas, VA 20110 USA 
4
Medical Biotechnology Center, University of Maryland Biotechnology Institute, Baltimore, MD 20201 USA 

10
10
2006

11
2006

34
11
1712
1728
4
1
2006

15
8
2006


© Springer Science+Business Media, LLC 2006

2+
2+
2+
2+
2+
 allowing free NFκB to translocate into the nucleus; and (3) the degradation of IκB is essential for efficient translocation of NFκB to the nucleus. Through sensitivity analysis, the model also suggests that the largest controlling factor for NFAT activation is the dissociation/reassociation rate of the NFAT:calcineurin complex and the translocation rate of the complex into the nucleus and for NFκB is the degradation/resynthesis rate of IκB and the import rate of IκB into the nucleus.

Keywords
Calcium
Computational model
T cell
Immune response

issue-copyright-statement
© Biomedical Engineering Society 2006




Introduction
2+
8
16
25
44
49
19
48
50
58

1
2+
34
45
59
10
51
2+
9
43
54
62

Figure 1.
i
i
i
 and dephosphorylates it, allowing its import into the nucleus where it can act on the DNA. (b) Schematic diagram of the mechanism of action of NFκB. At rest, NFκB is bound to its inhibitor IκB mainly in the cytosol (NFκB:IκB). Activation of calcineurin (C) synergizes with PKCα activating an early phase of the kinase IKK and activation of PKCθ activates a later phase of IKK which phosphorylates IκB. It then dissociates from NFκB allowing NFκB to be imported into the nucleus where it can act on the DNA.



1
7
14
2+
48
33
56
20
36
26

2+
11
21
2+
22
2+
22
39
15

23
58
 Other conditions related to defects in NFAT and NFκB activation include asthma, allergy, inflammation, and septic shock.
15
18
39
57
30
5
1

To understand better how signal transduction pathways function, to help find therapies and cures for immune system diseases, and to find better ways to control the immune system in transplant patients it would be useful to understand the NFAT and NFκB pathways in a quantitative fashion.

Models and Mechanisms
1
4
22
TABLE 1.
NFAT rate constants.

Rate constant
Value
Source


k
1

−1

Estimate

k
2

−1

34


k
3

−1

Estimate

k
4

−1

Estimate

k
5

−1

52


k
6

−1

52


k
7

−1

Estimate

k
8

−1

Estimate

k
9

−1

Estimate

k
10

−1

Estimate

k
11

−1
−1

51


k
12

−1

10


k
13

−1

32


k
14

−1

34


k
15

−1

10


k
16

−1
−1

51


k
17

−1

62


k
18

−1

62


k
19

−3
−1

32
29


k
20

−1

32
29


k
21

−1

k
22
 to give equal calcium ion concentrations in nucleus and cytoplasm

k
22

−1

Estimate




TABLE 2.
Concentration and volume parameters.

Parameter
Value
Source


Cell diameter
9000 nM
2
)

Nucleus diameter
6000 nM
2
)

n
)
3

Calculated

c
)
3

Calculated

2+
]
100 nM
2


2+
]
1000 nM
2


Total calcineurin concentration
60.0 nM
17


Total NFκB concentration
52.9 nM
13


Total NFAT concentration
7.23 nM
Estimate

Total IκB concentration
55.0 nM
13


Number calcium ions required to activate each calcineurin molecule
3
29


Total PKCθ concentration
2000 nM
Estimate

Total PKCα concentration
1000 nM
Estimate




TABLE 3.
PKCα membrane-binding parameters.

Parameter
Definition
Value
Source


K
Ca

Dissociation constant
22.0 μM
38


h

Calcium binding cooperativity
1.5
38


n

Stoichiometric coefficient
2 mol/mol
38


K
DAG

Dissociation constant
10.2 nM
3


[DAG]
Diacyl glycerol concentration
2000.0 nM
37


tr2a
IκB constitutive mRNA synthesis
−6
−1

25


tr2
IκB inducible mRNA synthesis
−2
−1
−1

25


tr3
IκB mRNA degradation
−4
−1

26





TABLE 4.
NFκB rate constants.

Rate constant
Value
Source


k
5

−1

52


k
6

−1

52


k
19

−3
−1

32
29


k
20

−1

32
29


k
21

−1

k
22 
to give equal calcium ion concentrations in nucleus and cytoplasm

k
22

−1

Estimate

k
23

−1
−1

14
27


k
24

−1

14


k
25

−1

22


k
26

−1
−1

22


k
27

−1

k
2
k
2
14


k
28

−1

12


k
29

−1

k
3
k
2
14


k
30

−1

Estimate

k
31

−1

Estimate

k
32

−1

Estimate

k
33

−1

Estimate

k
34

−1

Estimate

k
35

−1

56


k
36

−1

56


k
37

−1

56


k
38

−1

56


k
39

−1

56


k
40

−1

56


k
41

−1

60


k
42

−1

60


k
43

0.02
56


k
44

0.009
56






NFAT Model
1
i
40
46
31
*
) translocates to the nucleus, where it may bind to promoter regions of DNA and assist in initiation of gene transcription. A lowering of the calcium concentration results in deactivation of calcineurin and its dissociation from the NFAT-calcineurin complex. Free nuclear NFAT may then be phosphorylated by ubiquitous kinases, masking nuclear localization signals and resulting in translocation from the nucleus to the cytoplasm. Thus rising and falling calcium ion concentrations result in activation and deactivation of the transcription factor NFAT.
22
 (5) calcineurin binds three calcium ions to become active; and (6) NFAT and calcineurin clearly bind to other molecules in the cell, however, these interactions are ignored for simplicity.
2
i
c
2
n
2+
k
1
k
22
.
Figure 2.
i
i
, which enters the nucleus and associates with NFκB. The resulting complex dephosphorylates and is exported from the nucleus.



Using the law of mass action, this reaction scheme yields a system of 12 coupled first order differential equations describing the change in concentration with time for each of the 12 distinct chemical species (Appendix A). The parameters in the equations include the 22 rate constants and the number of calcium ions required to activate the phosphatase activity of each calcineurin molecule, designated by m in the figure. The time course for the concentrations of each of the chemical species from a given initial condition is determined by numerical solution of the system using a standard fourth order Runge–Kutta technique.
1
 lists the rate constants used in the NFAT model. They may be loosely divided into three groups: (1) calculated from published data, (2) estimated from published data, and (3) adjusted to fall within expected physiological ranges in order to make the model conform to published experimental data.

NFkB Model
1
55
56
28
IκB
61
20
6
 The NFκB:IκB complex is then exported from the nucleus to the cytoplasm.
26
22
 (4) the IKK kinases are lumped into one reaction; (5) in the model IκB represents IκBα; (6) the amount of free NFκB in the nucleus is used as a measure of the activation of the transcription factor; (7) calcineurin binds 3 calcium ions to become active; and (8) the binding of calcineurin, IκB, and NFκB to other molecules in the cell clearly occurs, but is not included in the model for simplicity.
2
2
n
k
5
k
6
k
19
k
42
k
41
k
42
26
 From the NFκB reaction scheme a system of 17 coupled first order differential equations may be written, one for the change in concentration with time of each of the 17 distinct chemical species (Appendix B). Given the initial concentration of each species, numerical integration of the system yields the time course of the concentration for each species.


Results and Discussion
1
4
 were used unless stated in the figure legends. The only difference in the simulated results was the calcium clamp protocol used.
NFAT Model Results
1
2
i
5
i
i
3
i
i
i
i
2
a show the NFAT activation pathway on the reaction scheme for NFAT. Calcineurin associates with calcium ion, activating calcineurin. The activated calcineurin associates with phosphorylated NFAT and dephosphorylates it. The NFAT:C* resulting from this dephosphorylation is rapidly imported to the nucleus where it is transcriptionally active.
Figure 3.
2
a) for the activation and deactivation of NFAT are determined by observing the sequence of the formation of the various species in the reaction scheme.



TABLE 5.
NFAT resting steady-state concentrations.

Species
Concentration (nM)


n

0.5219

c

0.1101

n

0.0505

c

0.0091

i
n

0.2272

i
c

9.4397

i
n

0.0025

i
c

0.0022

n

0.9477

c

0.0061

n

49.198

c

9.7108

n
2+

100

c
2+

100




3
3
n
n
i
n
2
n
 dissociates, free NFAT is phosphorylated and exported from the nucleus.
22
4
4
n
i
c
n
n
n
4
n
i
c
 rises, both approaching their resting levels as time increases.
Figure 4.
μ
μ
μ
μ
M average concentration when the calcium concentration oscillates.



4
n
n
4
22
3
22
24
 observed that the binding of 3 NFAT molecules to a constructed promoter on a DNA strand produced cooperativity of transcription. They also suggested a similar requirement for NFκB activation of gene expression. While inclusion of these factors would result in a more quantitatively accurate reproduction of the reporter gene expression data, we chose to simplify the model to emphasize the mechanisms for activation of the transcription factors.
22
4
4
22
2
c. The two calculated curves meet at a calcium concentration of 0.39 μM, very close to the 0.35 μM shown in the experimental work. This corresponds to a period of approximately 30 s. If the period is longer than 30 s (the average calcium is lower than 0.39 μM), then the oscillations are more potent than steady-state calcium with the same average at activating NFAT. If higher, the opposite is true. The model data shows enhanced NFAT activity down to about 0.2 μM, below which the activity decreases rapidly.
35
5
 shows the results obtained when the calcineurin concentration was increased as much as a factor of 25 times above the baseline concentration. The percent of NFAT in the transcriptionally active form does indeed increase when the calcineurin concentration increases, and high levels of activation are achieved with high calcineurin concentrations.
Figure 5.
μ
M) and the calcineurin concentration increased to simulate overexpression of calcineurin. Each data point shows the steady state concentration of transcriptionally active NFAT at a fixed calcineurin concentration. Overexpression of calcineurin replaces the requirement for calcium at fixed low calcium concentration.




NFκB Model Results
2
4
6
TABLE 6.
NFκB resting steady-state concentrations.

Species
Concentration (nM)


n

7.1779

c

0.0731

i
n

0.2035

i
c

0.0525

i
n

0.2343

i
c

0.1076

n

0.2376

c

52.961

n

0.0505

c

0.0091

n

49.198

c

9.7108

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\hbox{Ca}_{\rm n}^{2+}$$\end{document}


100

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$\hbox{Ca}_{\rm c}^{2+}$$\end{document}


100





6
i
6
2
56
 Activated IKK phosphorylates the NFκB:IκB complex in the cytoplasm. After dissociation, the phosphorylated IκB is polyubiquitinated and degraded, and free NFκB is imported to the nucleus where it may be transcriptionally active.
Figure 6.
κ
2
b can be determined by observing the time evolution of the concentration of the different reaction species.



6
2
22
3
7
22
 Both show activation of NFκB over the physiological range of calcium ion concentrations, with little activity at low concentrations and full activity at high concentrations. The sigmoidal shape of the calculated curve agrees with the experimental results.
Figure 7.
Dependence of the percent active NFκB on the steady-state calcium concentration. For each data point the calcium ion concentration was fixed at the indicated value.



8
a. The initial concentrations were those of the resting steady state and the oscillation period was 100 s. The calcium ion concentration was fixed at 1.0 μM during the initial 10 s of each period and at 0.1 μM for the remaining 90 s of each period. When the calcium concentration is high, the concentration of NFκB:IκB in the cytoplasm falls rapidly, and when the calcium concentration is low the concentration of this species increases slowly. The concentration of NFκB in the nucleus follows the reverse trend, increasing rapidly during the periods of high calcium concentration and falling more slowly when calcium concentration is low.
Figure 8.
μ
μ
κ
κ
κ
κ
κ
κ
κ
κ
κ
κ
κ
B to calcium concentration oscillations.



8
2+
c
 rises, to levels characteristic of the resting state.
8
22
3
b. Their figure shows over 90% gene expression with a 100 s period, falling to less than 20% gene expression for an 1800 s period. Note that they have determined percent gene expression while we calculate percent of transcriptionally active NFκB, a difference that may explain the quantitative difference in the results.
8
4
8
22
3
b, where gene expression by NFAT declined rapidly with oscillation frequency but persisted to long periods for NFκB.
9
60
2+
53
9
60
2
. They observed an increase in IκB concentration after about 40 min.
Figure 9.
κ
2+
κ
κ
κ
κ
κ
κ
κ
−1
.



9
k
41
−1
. As the degradation rate decreases below this value the percent of active NFκB decreases, thus a sufficiently high IκB degradation rate is required for efficient NFκB activation.


Sensitivity Analysis
10
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ \frac{\ln\frac{\left(\hbox{active transcription factor at} + 10\% \right)} {\left(\hbox{active transcription factor at} - 10\% \right)}} {\frac{\left(\hbox{rate constant times 1.1}\right)} {\left(\hbox{rate constant times 0.9 }\right)}} $$\end{document}


Figure 10.
(a) Sensitivity analysis for NFAT activation. (b) Sensitivity analysis for NFκB activation. In both cases, the rate constants were increased and decreased by 10%. The sensitivity of the steady state concentration of active transcription factor at 1.0 μM calcium to changes in the rate constants is shown.



10
k
9
k
10
k
13
k
14
k
15
k
16,
k
19
k
20
k
9
k
10
k
13
k
14
k
15
k
16
4
41
k
11
k
12
k
19
k
20
k
5
k
6
5
 and the experiments that demonstrate that increasing calcineurin increases the activation of NFAT.
10
k
30
k
41
k
42
k
23
k
24
k
25
k
26
k
27
k
28
k
43
k
44
k
41
k
42
9
k
43
k
44
k
30
k
29
k
23
k
24
k
25
k
26
k
27
k
28
, the rate of import NFκB to the nucleus, increases the amount of activation of NFκB. This effectively increases the amount of NFκB in the nucleus. It is interesting that although reducing the rate of phosphorylation of IKK by calcineurin does inhibit NFkB translocation to the nucleus, this is not one of the most sensitive parameters. The sensitivity analysis suggests that there are several other targets that will block NFAT and NFκB translocation. For several of the targets on NFAT, there is experimental data to support the model predictions about the sensitivities. On the other hand, the prediction that blocking of NFAT translocation decreases transcription has yet to be verified experimentally. This might be accomplished by developing a compound that either binds the nuclear import site of NFAT or that blocks the import mechanism. For NFκB the prediction of this analysis is that the most effective target would be to block IκB degradation or increase its re-synthesis. Another potent target would be to block NFκB translocation. Other possible interventions to block NFκB translocation would be to introduce compounds that increase the affinity of NFκB for IκB or that increase the activity of IKK. These are not the only possible sites as many accessory pathways regulate this system. Future studies that build on this model and explore these pathways will give further insight.

Conclusions
We have developed models for the calcium and PKCθ mediated activation and deactivation of the transcription factors NFAT and NFκB that incorporate experimentally determined reaction pathways and that simulate this action over physiological calcium concentrations. The model reproduces experimentally observed behaviors of both the NFAT and NFκB systems under a variety of conditions.
13
60
 would exert a greater influence on model results and thus its choice is more critical.
While the model is qualitatively accurate, simulation of the reporter gene levels observed by Dolmetsch and colleagues might be more closely approximated by the inclusion of additional features to the model. Several of these enhancements are obvious and consist of including elements both upstream and downstream of the system modeled. For example, binding of the transcription factors to the DNA might be added along with steps to describe the expression of the reporter genes observed in the experiment. Inclusion of these steps would require adding significant complexity to the model that might obstruct demonstration of the mechanisms governing activation of the calcium dependent transcription factors NFAT and NFκB. Thus, addition of these steps has been left for future work.
in vitro
in vivo
18
55
42
3
47

13
 describes the association and dissociation of NFκB and IκB and their translocation into the nucleus both in the associated and dissociated forms. Their model demonstrates that NFκB is localized in the cytoplasm at rest due to its association with IκB and the export of NFκB from the nucleus. A second model, developed by Hoffman and co-workers, demonstrated that the temporal control was due to coordinated degradation and resynthesis of IκB and that IκB provides a strong negative feedback that can turn off the NFκB response.


The authors would like to thank Jack Beusmans of AstraZeneca R & D Boston for helpful discussions. The authors would also like to thank the Texas Higher Education Coordinating Board for the Texas Advanced Research Program Grant that helped, in part, to support this work.

Appendix A – NFAT Model Equations
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{{d}[\hbox{NFATn}]}{dt}& = k_{1}[(\hbox{NFAT:P}_{\rm
i})_{\rm n}] -k_{2}[\hbox{NFAT}_{\rm n}]+k_{17}[\hbox{NFAT}_{\rm
c}]\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-k_{18}[\hbox{NFAT}_{\rm n}]\\
&\quad +k_{15}[(\hbox{NFAT:C})_{\rm n}]
-k_{16}[\hbox{NFAT}_{\rm n}][{\hbox{C}^{\ast}}_{\rm n}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{{d}[\hbox{NFAT}_{\rm c}]}{dt}& = {k}_{1}
[(\hbox{NFAT:P}_{\rm i})_{\rm c}]
-k_{2}[\hbox{NFAT}_{\rm c}]+k_{18}[\hbox{NFAT}_{\rm n}]
\frac{\hbox{v}_{\rm n}} {\hbox{v}_{\rm c}}-k_{17}[\hbox{NFAT}_{\rm c}]\\
&\quad +k_{15}[(\hbox{NFAT:C})_{\rm c}]
-k_{16}[\hbox{NFAT}_{\rm c}][\hbox{C}^\ast_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d[\hbox{C}^\ast_{\rm n}]}{dt}& = -k_{11}[(\hbox{NFAT:P}_{\rm i})_{\rm n}]
[\hbox{C}^\ast_{\rm n}]+k_{12}[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]
+k_{5}[\hbox{C}^\ast_{\rm c}]\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-k_{\rm 6}[\hbox{C}^\ast_{\rm n}]\\
&\quad +k_{15}[(\hbox{NFAT:C})_{\rm n}]-k_{16}[\hbox{C}^\ast_{\rm n}]
[\hbox{NFAT}_{\rm n}]+k_{19}[\hbox{C}_{\rm n}]
[\hbox{Ca}_{\rm n}^{2+}]^{m}-k_{20}
[\hbox{C}^\ast_{\rm n}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{{d}[\hbox{C}^\ast_{\rm c}]}{dt}& = -k_{11}
[(\hbox{NFAT:P}_{\rm i})_{\rm c}][\hbox{C}^\ast_{\rm c}]
+k_{12}[\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm c}]-k_{\rm
5}[\hbox{C}^\ast_{\rm c}]+k_{\rm 6}[\hbox{C}^\ast_{\rm n}]
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}\\
&\quad +{k}_{15}[(\hbox{NFAT:C})_{\rm c}]-k_{16}[\hbox{C}^\ast_{\rm c}]
[\hbox{NFAT}_{\rm c}]+k_{19}[\hbox{C}_{\rm c}]
[\hbox{Ca}_{\rm c}^{2+}]^{m}-k_{20}[\hbox{C}^\ast_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d\hbox{[(NFAT:P}_{\rm i})_{\rm n}]}{{dt}}& = -k_{\rm 1}
[(\hbox{NFAT:P}_{\rm i})_{\rm n}]+k_{\rm 2}[\hbox{NFAT}_{\rm n}]
-k_{\rm 4}[(\hbox{NFAT:P}_{\rm i})_{\rm n}]+k_{\rm 3}
[(\hbox{NFAT:P}_{\rm i} )_{\rm c} ]\frac{\hbox{v}_{\rm c}}
{\hbox{v}_{\rm n}}\\
&\quad-k_{11}[(\hbox{NFAT:P}_{\rm i})_{\rm n}]
[\hbox{C}^\ast_{\rm n}]+k_{12}
[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d\hbox{[(NFAT:P}_{\rm i})_{\rm c}]}{dt}& = -k_{\rm 1}
[(\hbox{NFAT:P}_{\rm i})_{\rm c}]+k_{\rm 2}[\hbox{NFAT}_{\rm c}]
-k_{3}[(\hbox{NFAT:P}_{\rm i})_{\rm c}]+k_{4}
[(\hbox{NFAT:P}_{\rm i})_{\rm n} ]\frac{\hbox{v}_{\rm n}
}{\hbox{v}_{\rm c}}\\
&\quad -k_{11}[(\hbox{NFAT:P}_{\rm i})_{\rm c}]
[\hbox{C}^\ast_{\rm c}]+k_{12}[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d\hbox{[(NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]}{dt}& = k_{11}
[(\hbox{NFAT:P}_{\rm i})_{\rm n}][\hbox{C}^\ast_{\rm n}]
-k_{12}[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]+k_{\rm 7}
[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm c}]\frac{\hbox{v}_{\rm c}}
{\hbox{v}_{\rm n}}\\
&\quad -k_{\rm 8}[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]
-k_{13}[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]
+k_{14}[(\hbox{NFAT:C})_{\rm n}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d\hbox{[(NFAT:P}_{\rm i}:\hbox{C})_{\rm c}]}{dt}& = k_{11}
[(\hbox{NFAT:P}_{\rm i})_{\rm c}][\hbox{C}^\ast_{\rm c}]
-k_{12}[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm c}]+k_{\rm 8}
[(\hbox{NFAT:P}_{\rm i}:\hbox{C})_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}\\
&\quad-k_{\rm 7}[(\hbox{NFAT:P}_{\rm i}
:\hbox{C})_{\rm c}]-k_{13}[(\hbox{NFAT:P}_{\rm i}
:\hbox{C})_{\rm c}]+k_{14}[(NFAT:\hbox{C})_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d\hbox{[(NFAT:C)}_{\rm n}]}{dt}& = k_{16}
[\hbox{NFAT}_{\rm n}][\hbox{C}^\ast_{\rm n}]-k_{15}
[(\hbox{NFAT:C})_{\rm n}]+k_{13}[(\hbox{NFAT}:P_{\rm i}:\hbox{C})_{\rm n}]\\
\quad -&k_{14}[(\hbox{NFAT}:\hbox{C})_{\rm n}]+k_{\rm 9}
[(\hbox{NFAT:C})_{\rm c}]\frac{\hbox{v}_{\rm c}}
{\hbox{v}_{\rm n}}-k_{10}[(\hbox{NFAT:C})_{\rm n}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d\hbox{[(NFAT:C)}_{\rm c}]}{dt}& = k_{16}
[\hbox{NFAT}_{\rm c}][\hbox{C}^\ast_{\rm c}]-k_{15}
[(\hbox{NFAT}:\hbox{C})_{\rm c}]+k_{13}[(\hbox{NFAT:P}_{\rm i}:
\hbox{C})_{\rm c}]\\
&\quad-k_{14}[(\hbox{NFAT:C})_{\rm c}]+
k_{10}[(\hbox{NFAT:C})_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}-k_{\rm 9}[(\hbox{NFAT:C})_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{C}_{\rm n}]}{dt} = k_{\rm 5}[\hbox{C}_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-k_{\rm 6}
[\hbox{C}_{\rm n}]-k_{19}[\hbox{C}_{\rm n}]
[\hbox{Ca}_{\rm n}^{2+}]^{m}
+k_{20}[\hbox{C}^\ast\hbox{n}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{{d}[\hbox{C}_{\rm c}]}{dt} = -k_{\rm 5}[\hbox{C}_{\rm c}]
-k_{\rm 6}[\hbox{C}_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}\hbox{c}-k_{19}[\hbox{C}_{\rm c}]
[\hbox{Ca}_{\rm c}^{2+}]^{m}+k_{20}[\hbox{C}^\ast_{\rm c}]
$$\end{document}



Appendix B – NFκB Model Equations
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{NF}\kappa\hbox{B}]_{\rm n}}{dt} = -{k}_{27}\hbox{[NF}\kappa
\hbox{B}_{\rm n}]+{k}_{28}\hbox{[NF}\kappa\hbox{B}_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-{k}_{23}\hbox{[NF}\kappa\hbox{B}_{\rm n}][\hbox{I}\kappa
\hbox{B}_{\rm n}]+{k}_{24}[(NF\kappa B:I\kappa B:P_{\rm i})_{\rm n}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{NF}\kappa\hbox{B}]_{\rm c}}{dt} = -{k}_{28}\hbox{[NF}\kappa
\hbox{B}_{\rm c}]+{k}_{27}\hbox{[NF}\kappa
\hbox{B}_{\rm n}]\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}
-{k}_{23}\hbox{[NF}\kappa\hbox{B}_{\rm c}][\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{24}[(NF\kappa B:I\kappa B:P_{\rm i})_{\rm c}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{I}\kappa\hbox{B}]_{\rm n}}{dt} = -{k}_{29}\hbox{[I}\kappa
\hbox{B}_{\rm n}]+{k}_{30}\hbox{[I}\kappa
\hbox{B}_{\rm c}]\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-{k}_{23}\hbox{[NF}\kappa\hbox{B}_{\rm n}][\hbox{I}\kappa
\hbox{B}_{\rm n}]+{k}_{24}[(NF\kappa B:I\kappa B:P_{\rm i})_{\rm n}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d[\hbox{I}\kappa\hbox{B}]_{\rm c}}{dt}& = -{k}_{30}[\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{29}[\hbox{I}\kappa
\hbox{B}_{\rm n}]\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}
-{k}_{23}[\hbox{NF}\kappa\hbox{B}_{\rm c}][\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{24}\hbox{[(NF}\kappa
\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}] \\
&-{k}_{41}[\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{42}[I\kappa B_{t}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{I}\kappa\hbox{B}]_{\rm t}}{dt} = \hbox{tr2a}+\hbox{tr2}[\hbox{NF}\kappa\hbox{B}_{\rm n}]-\hbox{tr3}[\hbox{I}\kappa\hbox{B}_{\rm t}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i}]_{\rm n}}{dt}& = {k}_{23}
\hbox{[NF}\kappa \hbox{B}_{\rm n}][\hbox{I}\kappa\hbox{B}_{\rm n}]
-{k}_{24}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]
-{k}_{25}[(\hbox{NF}\kappa \hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]\\
&\quad +k_{32}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-k_{31}
[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i}]_{\rm c}}{dt}& = {k}_{23}
\hbox{[\hbox{NF}}\kappa\hbox{B}_{\rm c}][\hbox{I}\kappa\hbox{B}_{\rm c}]
-{k}_{25}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
+{k}_{26}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}][\hbox{IKK}^{\ast}]\\
&\quad-{k}_{24}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
+{k}_{31}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}-{k}_{32}
[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B}]_{\rm n}}{dt} = {k}_{25} \hbox{[(\hbox{NF}}\kappa\hbox{B:I}\kappa \hbox{B:P}_{\rm i})_{\rm n}]
+{k}_{34}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-{k}_{33}
[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm n}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B}]_{\rm c}}{dt}& = {k}_{25}
\hbox{[(\hbox{NF}}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
-{k}_{26}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}][\hbox{IKK}^\ast]
+{k}_{33}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}\\
&\quad-{k}_{34}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}]\\
\end{aligned}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{C}^\ast]_{\rm n}}{dt} = -{k}_{20}[{\hbox{C}^\ast}_{\rm n}]
+{k}_{19}[\hbox{C}_{\rm n}][\hbox{Ca}_{\rm n}^{2+}]^{\rm p}-
{k}_{\rm 6}[{\hbox{C}^\ast}_{\rm n}]+{k}_{\rm 5}
[{\hbox{C}^{\ast}}_{\rm c}]\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{C}^{\ast}]_{\rm c}}{dt} = -k_{20}[{\hbox{C}^{\ast}}_{\rm c}]+k_{19}
[\hbox{C}_{\rm c}][\hbox{Ca}_{\rm c}^{2+}]^{\rm p}+{k}_{\rm 6}[{\hbox{C}^{\ast}}_{\rm n}]
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}-k_{\rm 5}[{C^{\ast}}_{\rm c}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{C}]_{\rm n}}{dt} = {k}_{20}[{\hbox{C}^\ast}_{\rm n}]
-{k}_{19}[\hbox{C}_{\rm n}][\hbox{Ca}_{\rm n}^{2+}]^{\rm p}
+{k}_{\rm 5}[\hbox{C}_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-{k}_{\rm 6}[\hbox{C}_{\rm n}]
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{C}]_{\rm c}}{dt} = {k}_{20}[{\hbox{C}^{\ast}}_{\rm c}]-{k}_{19}
[\hbox{C}_{\rm c}][\hbox{Ca}_{\rm c}^{2+} ]^{\rm p}-{k}_{5}
[\hbox{C}_{\rm c}]+{k}_{6}[\hbox{C}_{\rm n}]
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d{f}_{\rm later IKK^{\ast}}}{{dt}} = {k}_{35}
(1-{f}_{\rm later IKK^{\ast}})[{\hbox{PKC}\theta}^{\ast}]
-{k}_{36}f_{{\rm later IKK}^{\ast}}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d{f}_{{\rm early IKK}^{\ast}}}{{dt}} = {k}_{37}
(1-f_{{\rm early IKK}^{\ast}})[\hbox{PKC}\alpha\ast]
-{k}_{38}{f}_{{\rm early IKK}^{\ast}}+{k}_{39}
(1-{f}_{{\rm early IKK}^{\ast}})[{\hbox{C}_{\rm n}}^{\ast}]
-{k}_{40}{f}_{{\rm early IKK}^{\ast}}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{{df}_{{{\rm IKK}_{\rm c}}^{\ast}}}
{{dt}} = \frac{{df}_{{\rm early IKK}^{\ast}}}
{{dt}}+\frac{{df}_{{\rm later IKK}^{\ast}}}
{{dt}}+{k}_{43}{f}_{{{\rm IKK}_{\rm n}}^{\ast}}
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}-{k}_{44}
{f}_{{{\rm IKK}_{\rm c}}^{\ast}}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{{df}_{{{\rm IKK}_{\rm n}}^{\ast}}}
{\hbox{dt}} = {k}_{44}{f}_{{{\rm IKK}_{\rm c}}^{\ast}}
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-{k}_{43}
{f}_{{{\rm IKK}_{\rm n}}^{\ast}}
$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
[\hbox{PKC}\alpha^{\ast}] = [\hbox{PKC}\alpha]_{\rm total}\times n
\left(\frac{[\hbox{Ca}]^{\rm h}}{[\hbox{Ca}]^{\rm h}+K_{\hbox{Ca}}^{\rm h}}\right)\times
\left(\frac{[\hbox{DAG}]}{[\hbox{DAG}]+K_{\rm DAG}}\right)
$$\end{document}




References
1.
Abbott
K. L.

Friday
B. B.

Thaloor
D.

Murphy
T. J.

Pavlath
G. K.


Activation and cellular localization of cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells
Mol. Biol. Cell.
1998
9
2905
2916

9763451


2.
Alberts
B.

Bray
D.

Lewis
J.

Raff
M.

Roberts
K.

Watson
J. D.


Molecular Biology of the Cell
1989
New York
Garland Publishing, Inc.

Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J. D. (1989)  Molecular Biology of the Cell. Garland Publishing, Inc., New York 

3.
Ananthanarayanan
B.

Stahelin
R. V.

Digman
M. A.

Cho
W.


Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains
J. Biol. Chem.
2003
278
47
46886
46894
10.1074/jbc.M307853200

12954613


4.
Aramburu
J.

Garcia-Cozar
F.

Raghavan
A.

Okamura
H.

Rao
A.

Hogan
P. G.


Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT
Mol. Cell.
1998
1
627
637
10.1016/S1097-2765(00)80063-5

9660947


5.
Aramburu
J.

Yaffe
M. B.

López-Rodríguez
C.

Cantley
L. C.

Hogan
P. G.

Rao
A.


Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A
Science
1999
285
2129
2133
10.1126/science.285.5436.2129

10497131


6.
Arenzana-Seisdedos
F.

Turpin
P.

Rodriguez
M.

Thomas
D.

Hay
R. T.

Virelizier
J.-L.

Dargemont
C.


Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm
J. Cell Sci.
1997
110
369
378

9057089


7.
Baeuerle
P. A.

Baltimore
D.


IκB: A specific inhibitor of NF-κB transcription factor
Science
1988
242
540
546
10.1126/science.3140380

3140380


8.
Baeuerle
P. A.

Baltimore
D.


NF-κB: Ten years after
Cell
1998
87
13
20
10.1016/S0092-8674(00)81318-5

8858144


9.
Beals
C. R.

Sheridan
C. M.

Turck
C. W.

Gardner
P.

Crabtree
G. R.


Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
Science
1997a
275
1930
1933
10.1126/science.275.5308.1930

9072970


10.
Beals
C. R.

Clipstone
N. A.

Ho
S. N.

Crabtree
G. R.


Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular reaction
Genes Dev.
1997b
11
824
834

9106655


11.
Berridge
M. J.

Galione
A.


Cytosolic calcium oscillators
FASEB J.
1988
2
3074
3082

2847949


12.
Birbach
A.

Gold
P.

Binder
B. R.

Hofer
E.

Martin
R.

Schmid
J. A.


Signaling molecules of the NF-κB pathway shuttle constitutively between cytoplasm and nucleus
J. Biol. Chem.
2002
277
10842
10851
10.1074/jbc.M112475200

11801607


13.
Carlotti
F.

Chapman
R.

Dower
S. K.

Qwarnstrom
E. E.


Activation of nuclear factor κB in single living cells
J. Biol. Chem.
1999
274
37941
37949
10.1074/jbc.274.53.37941

10608861


14.
Carlotti
F.

Dower
S. K.

Qwarnstrom
E. E.


Dynamic shuttling of nuclear factor κB between the nucleus and cytoplasm as a consequence of inhibitor dissociation
J. Biol. Chem.
2000
275
41028
41034
10.1074/jbc.M006179200

11024020


15.
Clipstone
N. A.

Crabtree
G. R.


Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
Nature
1992
357
695
697
10.1038/357695a0

1377362


16.
Coudronniere
N.

Villalba
M.

Englund
N.

Altman
A.


NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta
Proc. Natl. Acad. Sci. USA
2000
97
7
3394
3399
10.1073/pnas.060028097

10716728


17.
Crabtree
G. R.


2+
, calcineurin, and NF-AT
Cell
1999
96
611
614
10.1016/S0092-8674(00)80571-1

10089876


18.
Crabtree
G. R.


Calcium, calcineurin, and the control of transcription
J. Biol. Chem.
2001
276
2313
2316
10.1074/jbc.R000024200

11096121


19.
Crabtree
G. R.

Olson
E. N.


NFAT signaling: Choreographing the social lives of cells
Cell
2002
109
S67
S79
10.1016/S0092-8674(02)00699-2

11983154


20.
DiDonato
J. A.

Hayakawa
M.

Rothwarf
D. M.

Zandi
E.

Karin
M.


A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
Nature
1997
388
548
554
10.1038/41493

9252186


21.
Dolmetsch
R. E.

Lewis
R. S.


2+
2+
2+
i
 oscillations in T lymphocytes
J. Gen. Physiol.
1994
103
365
388
10.1085/jgp.103.3.365

8195779


22.
Dolmetsch
R. E.

Xu
K.

Lewis
R. S.


Calcium oscillations increase the efficiency and specificity of gene expression
Nature
1998
392
933
936
10.1038/31960

9582075


23.
Feske
S.

Draeger
R.

Peter
H.-H.

Eichmann
K.

Rao
A.


The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells
J. Immunol.
2000
165
297
305

10861065


24.
Fiering
S.

Northrop
J. P.

Nolan
G. P.

Mattila
P. S.

Crabtree
G. R.

Herzenberg
l. A.


Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor
Genes. Dev.
1990
4
1823
1834

2123468


25.
Ghosh
S.

May
M. J.

Kopp
E. B.


NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
Annu. Rev. Immunol.
1998
16
225
260
10.1146/annurev.immunol.16.1.225

9597130


26.
Hoffmann
A.

Levchenko
A.

Scott
M. L.

Baltimore
D.


The IκB-NF-κB signaling module: Temporal control and selective activation
Science
2002
298
1241
1245
10.1126/science.1071914

12424381


27.
Huang
T. T.

Kudo
N.

Yoshida
M.

Miyamoto
S.


A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/ IκBα complexes
Proc. Natl. Acad. Sci. USA
2000
97
1014
1019
10.1073/pnas.97.3.1014

10655476


28.
Huang
J.

Lo
P.

Zal
T.

Gascoigne
N. R. J.

Smith
B. A.

Levin
S. D.

Grey
H. M.


CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse
Proc. Natl. Acad. Sci. USA
2002
99
14
9369
9373
10.1073/pnas.142298399

12077322


29.
Kakalis
L. T.

Kennedy
M.

Sikkink
R.

Rusnak
F.

Armitage
I. M.


Characterization of the calcium-binding sites of calcineurin B
FEBS Lett.
1995
362
55
58
10.1016/0014-5793(95)00207-P

7698353


30.
Kiani
A.

Rao
A.

Aramburu
J.


Manipulating immune responses with immunosuppressive agents that target NFAT
Immunity
2000
12
359
372
10.1016/S1074-7613(00)80188-0

10795734


31.
Klee
C. B.

Draetta
G. F.

Hubbard
M. J.


Calcineurin
Adv. Enzymol. Relat. Areas
1988
61
149
200

Klee C. B., Draetta G. F., Hubbard M. J. (1988)  Calcineurin. Adv. Enzymol. Relat. Areas 61:149–200 

32.
Klee
C. B.

Ren
H.

Wang
X.


Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
J. Biol. Chem.
1998
273
13367
13370
10.1074/jbc.273.22.13367

9593662


33.
Mol. Cell Biol
. 20(8):2933–2940, 2000

34.
J. Biol. Chem
. 271:10884–10891, 1996

35.
Luo
C.

Shaw
K.T.-Y.

Raghavan
A.

Aramburu
J.

Garcia-Cozar
F.

Perrino
B.A.

Hogan
P.G.

Rao
A.


Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import
Proc. Natl. Acad. Sci.
1996
93
8907
8912
10.1073/pnas.93.17.8907

8799126


36.
Mercurio
F.

Zhu
H.

Murray
B. W.

Shevchenko
A.

Bennett
B. L.

Li
J.

Young
D. B.

Barbosa
M.

Mann
M.

Manning
A.

Rao
A.


IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
Science
1997
278
860
866
10.1126/science.278.5339.860

9346484


37.
Mogami
H.

Zhang
H.

Suzuki
Y.

Urano
T.

Saito
N.

Kojima
I.

Petersen
O. H.


2+
 influx signals into long term substrate phosphorylation through activation of two distinct classes of protein kinase C
J. Biol Chem.
2003
278
11
9896
9904
10.1074/jbc.M210653200

12514176


38.
Nalefski
E. A.

Slazas
M. M.

Falke
J. J.


2+
-signaling cycle of a membrane-docking C2 domain
Biochemistry
1997
36
40
12011
12018
10.1021/bi9717340

9340010


39.
O’Keefe
S. J.

Tamura
J.

Kincaid
R. L.

Tocci
M. J.

O’Neill
E. A.


FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
Nature
1992
357
692
694
10.1038/357692a0

1377361


40.
Okamura
H.

Aramburu
J.

Garcia-Rodriguez
C.

Viola
J. P.

Raghavan
A.

Tahilia
M.

Zhang
X.

Qin
J.

Hogan
P. G.

Rao
A.


Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity
Mol. Cell.
2000
6
539
550
10.1016/S1097-2765(00)00053-8

11030334


41.
Park
S.

Motonari
U.

Verdine
G. L.


A second calcineurin binding site on the NFAT regulatory domain
Proc. Natl. Acad. Sci. USA
2000
97
7130
7135
10.1073/pnas.97.13.7130

10860980


42.
Pfeifhofer
C.

Kofler
K.

Gruber
T.

Tabrizi
N. G.

Lutz
C.

Maly
K.

Leitges
M.

Baier
G.


2+
 mobilization and NFAT cell activation in primary mouse T cells
J. Exp. Med.
2003
197
1525
1535
10.1084/jem.20020234

12782715


43.
Porter
C. M.

Havens
M. A.

Clipstone
N. A.


Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization
J. Biol. Chem.
2000
275
3543
3551
10.1074/jbc.275.5.3543

10652349


44.
Rao
A.

Luo
C.

Hogan
P. G.


Transcription factors of the NFAT family: Regulation and function
Annu. Rev. Immunol.
1997
15
707
747
10.1146/annurev.immunol.15.1.707

9143705


45.
Ruff
V. A.

Leach
K. L.


Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody
J. Biol. Chem.
1995
270
22602
22607
10.1074/jbc.270.38.22602

7545680


46.
Salazar
C.

Höfer
T.


Allosteric regulation of the transcription factor NFAT1 by multiple phosphorylation sites: A mathematical analysis
J. Mol. Biol.
2003
327
31
45
10.1016/S0022-2836(03)00085-8

12614606


47.
San-Antonio
B.

Íñiguez
M. A.

Fresno
M.


Protein kinase Cζ phophorylates nuclear factor of activated T cells and regulates its transactivating activity
J. Biol. Chem.
2002
277
27073
27080
10.1074/jbc.M106983200

12021260


48.
Schaeffer
E. M.

Schwartzberg
P. L.


Tec family kinases in lymphocyte signaling and function
Curr. Opin. Immunol.
2000
12
282
288
10.1016/S0952-7915(00)00088-1

10781397


49.
Serfling
E.

Berberich-Siebelt
F.

Chuvpilo
S.

Jankevics
E.

Klein-Hessling
S.

Twardzik
T.

Avots
A.


The role of NF-AT transcription factors in T cell activation and differentiation
Biochim. Biophys. Acta
2000
1498
1
18
10.1016/S0167-4889(00)00082-3

11042346


50.
Shaw
J.-P.

Utz
P. J.

Durand
D. B.

Toole
J. J.

Emmel
E. A.

Crabtree
G. R.


Identification of a putative regulator of early T cell activation genes
Science
1988
241
202
205
10.1126/science.3260404

3260404


51.
Shaw
K. T.-Y.

Ho
A. M.

Raghavan
A.

Kim
J.

Jain
J.

Park
J.

Sharma
S.

Rao
A.

Hogan
P. G.


Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells
Proc. Natl. Acad. Sci. USA
1995
92
11205
11209
10.1073/pnas.92.24.11205

7479966


52.
Shibasaki
F.

Price
E. R.

Milan
D.

McKeon
F.


Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4
Nature
1996
382
370
373
10.1038/382370a0

8684469


53.
Szamel
M.

Appel
A.

Schwinzer
R.

Resch
K.


Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR
J. Immunol.
1998
160
5
2207
2214

9498759


54.
Timmerman
L. A.

Clipstone
N. A.

Ho
S. N.

Northrop
J. P.

Crabtree
G. R.


2+
 signals and immunosuppression
Nature
1996
383
837
840
10.1038/383837a0

8893011


55.
Trushin
S. A.

Pennington
K. N.

Algeciras-Schimnich
A.

Paya
C. V.


Protein kinase C and calcineurin synergize to activate IκB kinase and NFκB in T Lymphocytes
J. Biol. Chem.
1999
274
22923
22931
10.1074/jbc.274.33.22923

10438457


56.
Trushin
S. A.

Pennington
K. N.

Carmona
E. M.

Asin
S.

Savoy
D. N.

Billadeau
D. D.

Paya
C. V.


Protein kinase Cα (PKCα) acts upstream of PKCθ to activate IκB kinase and NF-κB in T lymphocytes
Mol. Cell. Biol.
2003
23
7068
7081
10.1128/MCB.23.19.7068-7081.2003

12972622


57.
Villalba
M.

Altman
A.


Protein Kinase C-θ (PKCθ), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias
Curr. Cancer Drug Targets
2002
2
2
125
137
10.2174/1568009023333908

12188914


58.
Wechsler
A. S.

Gordon
M. C.

Dendorfer
U.

LeClair
K. P.


Induction of IL-8 expression in T cell uses the CD28 costimulatory pathway
J. Immunol.
1994
153
2515
2523

8077662


59.
Wesselborg
S.

Fruman
D. A.

Sagoo
J. K.

Bierer
B. E.

Burakoff
S. J.


Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp)
J. Biol. Chem.
1996
271
1274
1277
10.1074/jbc.271.3.1274

8576111


60.
Yang
L.

Chen
H.

Qwarnstrom
E.


Degradation of IκBα is limited by a postphosphorylation/ubiquitination event
Biochem. Biophys. Res. Commun.
2001
285
603
608
10.1006/bbrc.2001.5205

11453635


61.
Yaron
A.

Hatzubai
A.

Davis
M.

Lavon
I.

Amit
S.

Manning
A. M.

Andersen
J. S.

Mann
M.

Mercurio
F.

Ben-Neriah
Y.


Identification of the receptor component of the IκBα-ubiquitin ligase
Nature
1998
396
590
594
10.1038/25159

9859996


62.
Zhu
J.

McKeon
F.


NF-AT activation requires suppression of Crm1-dependent export by calcineurin
Nature
1999
398
256
260
10.1038/18473

10094050



Abbreviations
NFAT
nuclear factor of activated T cells


NFκB
nuclear factor κB


PKC
protein kinase C


DAG
diacyl glycerol


IκB
inhibitor for NFκB


IKK
IκB kinase


C
calcineurin


IL
interleukin


TCR
T cell receptor


i

phosphate






